SCHEMBL19084395

SCHEMBL19084395

CCC[C@@H]1C[C@H](C)C2C(=O)N(CC3CCCCC3CN3CCN(C4=NS(=O)(=O)c5ccccc54)CC3)C(=O)C21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
LDHA P00338 1/20 0.42
DRD2 P14416 2/20 0.42
ADRA2C P18825 2/20 0.42
HTR2A P28223 2/20 0.42
HTR2B P41595 2/20 0.42
ABCB11 O95342 1/20 0.42
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADRA2B P18089 1/20 0.42
DRD1 P21728 1/20 0.42
TBXA2R P21731 1/20 0.42
ACHE P22303 1/20 0.42
SLC6A2 P23975 1/20 0.42
PDE4A P27815 1/20 0.42
HTR2C P28335 1/20 0.42
CCKAR P32238 1/20 0.42
HTR7 P34969 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18673156 0.81 ALDH1A1 (0.44) ALDH1A1LDHADRD2ADRA2CHTR2A
SCHEMBL16804116 0.81 ALDH1A1 (0.49) ALDH1A1LDHADRD2ADRA2CHTR2A
SCHEMBL19084426 0.78 HTR2B (0.55) ALDH1A1LDHADRD2ADRA2CHTR2A
SCHEMBL19084441 0.77 DRD2 (0.72) DRD2ADRA2CHTR2AHTR2BABCB11
SCHEMBL19772731 0.70 DRD2 (0.72) DRD2ADRA2CHTR2AHTR2BABCB11
SCHEMBL12653143 0.67 DRD2 (0.81) DRD2ADRA2CHTR2AHTR2BABCB11
SCHEMBL12653640 0.67 DRD2 (0.81) DRD2ADRA2CHTR2AHTR2BABCB11
SCHEMBL12653550 0.67 DRD2 (0.81) DRD2ADRA2CHTR2AHTR2BABCB11
SCHEMBL19084383 0.67 CA1 (0.36) SMN1; SMN2L3MBTL1
SCHEMBL12445891 0.66 DRD2 (0.62) ALDH1A1DRD2ADRA2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170192025-A1 METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY AMERITOX LLC (US) 2017-07-06 US disclosed